As Congress moves toward possible approval of a new prescription drug program for Medicare recipients later this summer, how payments for cancer drugs and therapeutic services are determined may well hang in the balance.
Latex Gloves and the Americans With Disabilities Act
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD
I Charged My Patient: I Was Sued
Residency Is Ending Soon: Key Financial Tips for Your Next Chapter
Career Insights: Advocating and Negotiating for PAs